| Literature DB >> 35533727 |
Esdras Antonio Fernández-Morales1, Gustavo Bermudez2, Hilda Montero3, Manuel Luzania-Valerio3, Roberto Zenteno-Cuevas4.
Abstract
The purpose of this work was to perform by Whole Genomic Sequencing (WGS) a characterization of tuberculosis isolates circulating in the central region of Veracruz, Mexico, and to determine its geographical distribution. The genome of 25 clinical isolates of tuberculosis patients, recovered from central zone of Veracruz, Mexico, were sequenced and the information obtained was used to characterize lineage, prediction of drug resistance, identification of clonal complexes, and finally correlated with the geolocalization data. Isolates analyzed were included into seven L4 sublineages, most frequent was X3; X1 (4.1.1.3) in 35%. rpoBSer450Leu polymorphism was the most frequently found variant. Sublineage Haarlem (4.1.2) had the widest distribution, found in five municipalities. Of the of two clonal complexes found, the most abundant included eight isolates, with X3/X1 lineage, placed in two municipalities. Combination of WGS and geographic information system was very useful for the identification of sublineages, clonal complexes, and their geographical dispersion with important implications in the epidemiological surveillance and clinical control of TB.Entities:
Keywords: Geolocation; Tuberculosis; WGS
Mesh:
Substances:
Year: 2022 PMID: 35533727 PMCID: PMC9387445 DOI: 10.1016/j.bjid.2022.102357
Source DB: PubMed Journal: Braz J Infect Dis ISSN: 1413-8670 Impact factor: 3.257
Fig. 1(A) Geographical distribution of M. tuberculosis lineages circulating in the center region of Veracruz, México. (B) Phylogenetic tree of isolates of circulating showing, lineages and clonal complexes found in the center region of Veracruz, Mexico.
Genotypic (r) vs phenotypic (R) drug sensitivity profile of drug resistant isolates circulating in center region of Veracruz, Mexico.*
| Isolate (Lineage) | Phenotypic (R) vs genotypic (r) resistance | Isoniazid (H) | Rifampicin (R) | Ethambutol (E) embB | Pyrazinamide (Z) | Fluoroquinolone (FQ) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| H | R | E | Z | 2155168 Ser15Thr agc/acc | 761108 Met 434 Ile atg/att | 761109 Asp435Tyr gac/tac | 761155 Ser450Leu tcg/ttg | 4247431 Met 306 Ile atg/att | 2288883 Leu120Pro ctg/ccg | 7582 Asp94Gly gac/ggc | |
| MX06 (LAM3; 4.3.2) | R/r | + | |||||||||
| MX164 (Haarlem; 4.1.2) | R/r | + | |||||||||
| MX238 (Haarlem; 4.1.2) | R/r | + | + | ||||||||
| MX906 (LAM9; 4.3.3) | R/- | R/- | |||||||||
| MX03 (X3/X1) | -/r | + | |||||||||
| MX12 (X3/X1) | -/r | -/r | -/r | + | + | + | |||||
| MX491 (X3/X1) | + | + | + | ||||||||
| MX454 (X3/X1) | R/r | R/r | -/r | + | + | + | |||||
| MX1040 (X3/X1) | + | + | + | + | |||||||
| MX1228 (X3/X1) | R/r | R/r | R/r | + | + | + | |||||
| MX1305 (X3/X1) | R/r | R/r | R/r | + | + | + | + | ||||
Twelve isolates were sensitive by drug resistance profile and confirmed by WGS.